Activity Prediction of Hormone-Sensitive Lipase Inhibitors Based on Machine Learning Methods

被引:3
|
作者
Lue Wei [1 ]
Xue Ying [1 ,2 ]
机构
[1] Sichuan Univ, Coll Chem, Minist Educ, Key Lab Green Chem & Technol, Chengdu 610064, Peoples R China
[2] Sichuan Univ, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
基金
中国国家自然科学基金;
关键词
Support vector machine; Hormone-sensitive lipase; Machine learning method; Molecular descriptor; Recursive feature elimination; SUPPORT VECTOR MACHINE; INSULIN-RESISTANCE; POTENT INHIBITORS; PATHOGENESIS; CLASSIFICATION; AFFINITY; ARYL;
D O I
10.3866/PKU.WHXB20100125
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Hormone-sensitive lipase (HSL) is known as the key rate-limiting enzyme responsible for regulating free fatty acids (FFAs) metabolism in adipose tissue. Recently, HSL has been found to be useful in the treatment of diabetes so the discovery of new HSL inhibitors (HSLIs) is of interest. Methods for the prediction of HSLIs are highly desired to facilitate the design of novel diabetes therapeutic agents because limited knowledge exists concerning the mechanism and three dimensional (3D) structure of hormone-sensitive lipase. We have explored several machine teaming methods (support vector machines (SVM), k-nearest neighbor (k-NN), and C4.5 decision tree (C4.5 DT)) to predict desirable HSLIs from a comprehensive set of known HSLIs and non-HSLIs. Our prediction system was tested using 252 compounds (123 HSLIs and 1.29 non-HSLIs) and these are significantly more diverse in chemical structure than those in other studies. The recursive feature elimination selection method was used to improve the prediction accuracy and to select the molecular descriptors responsible for distinguishing HSLIs and non-HSLIs. Prediction accuracies were 85.7%-90.5% for HSLIs, 63.2%-68.4% for non-HSLIs, and 75.0%-80.0% for all structures based on three kinds of machine teaming methods using an independent validation set. SVM gave the best total accuracy of 80.0% for all the structures. This work suggests that machine teaming methods such as SVM are useful to predict the potential HSLIs among unknown sets of compounds and to characterize the molecular descriptors associated with HSLIs.
引用
收藏
页码:471 / 477
页数:7
相关论文
共 50 条
  • [21] Regulation and role of hormone-sensitive lipase activity in human skeletal muscle
    Watt, MJ
    Spriet, LL
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2004, 63 (02) : 315 - 322
  • [22] Stimulation of hormone-sensitive lipase activity by contractions in rat skeletal muscle
    Langfort, J
    Ploug, T
    Ihlemann, J
    Holm, C
    Galbo, H
    BIOCHEMICAL JOURNAL, 2000, 351 (01) : 207 - 214
  • [23] Hormone-sensitive lipase - structure, function and regulation
    Anthonsen, MW
    Contreras, JA
    Fourel, D
    Holst, LS
    Karlsson, M
    Laurell, H
    Osterlund, T
    Holm, C
    PROGRESS IN OBESITY RESEARCH: 8, 1999, : 89 - 96
  • [24] Hormone-sensitive lipase: sixty years later
    Recazens, Emeline
    Mouisel, Etienne
    Langin, Dominique
    PROGRESS IN LIPID RESEARCH, 2021, 82
  • [25] The effects of tolbutamide on lipoproteins, lipoprotein lipase and hormone-sensitive lipase
    Agardh, CD
    Björgell, P
    Nilsson-Ehle, P
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 46 (02) : 99 - 108
  • [26] Letting lipids go: hormone-sensitive lipase
    Haemmerle, G
    Zimmermann, R
    Zechner, R
    CURRENT OPINION IN LIPIDOLOGY, 2003, 14 (03) : 289 - 297
  • [27] HORMONE-SENSITIVE LIPASE OF ADIPOSE-TISSUE
    STEINBERG, D
    KHOO, JC
    FEDERATION PROCEEDINGS, 1977, 36 (07) : 1986 - 1990
  • [28] Effect of phosphorylation on the conformation of hormone-sensitive lipase
    Keithly, Mary E.
    Dutta, Supratik
    Dupureur, Cynthia M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [29] HORMONE-SENSITIVE LIPASE + MONOGLYCERIDE LIPASE ACTIVITIES IN ADIPOSE TISSUE
    VAUGHAN, M
    BERGER, JE
    STEINBERG, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1964, 239 (02) : 401 - +
  • [30] Characterization of the interaction of hormone-sensitive lipase with lipotransin
    Shen, WJ
    Szeto-Ho, W
    Natu, V
    Greenberg, AS
    Kraemer, FB
    DIABETES, 2002, 51 : A464 - A465